Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sound waves aimed at brain may quiet shaky hands

NCT ID NCT07508696

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a precise beam of ultrasound directed at a small part of the brain (the dentate nucleus) can reduce tremor. First, 30 healthy volunteers will have their hand tremor measured during ultrasound to find the best settings. Then, 30 people with essential tremor will receive the same ultrasound to see if it calms their shaking. The goal is to see if this non-invasive approach can temporarily ease tremor without surgery or drugs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
focused ultrasound device (NeuroFUS Pro)
What this could lead to
If it works, this could point toward a non-invasive, drug-free way to temporarily ease essential tremor symptoms.
What could go wrong
This is a very early, small study (60 people total) testing short-term effects only. It may not lead to a lasting treatment, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Experiment 1: Healthy Volunteers 1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures 2. Participants aged 18-55 years 3. Male of female 4. Good health with no history of serious mental illness or implanted metal 5. Willingness to adhere to the TUS and MRI study schedule 6. Willingness to avoid caffeine and alcohol intake for at least 2 h prior to the investigation * Experiment 2: ET Patients 1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures 2. Participants aged 18-75 years 3. Male of female 4. Diagnosis of ET as confirmed from clinical history and examination by a movement disorder neurologist 5. Willingness to adhere to the TUS and MRI study schedule 6. Willingness to avoid caffeine and alcohol intake for at least 2 h prior to the investigation Exclusion Criteria: * Experiment 1: Healthy volunteers 1. Currently taking any psychotropic medication 2. Any head trauma resulting in loss of consciousness 3. Diagnosed with a serious mental illness 4. Alcohol or substance abuse or dependence (other than tobacco) in the past week 5. Currently in treatment for a psychiatric condition 6. Pregnancy (a test will be scheduled by the research team) 7. Personal or family history of seizures or epilepsy 8. Claustrophobia or inability to stay still in the MR scanner environment 9. Any metal in the body that is not MRI-compatible 10. Serious history of migraines 11. Hair in dreadlocks, braids, or weave (not possible to position ultrasound transducer) 12. orthopedic forearm or hand problems 13. Inability to adhere to the experimental schedule. * Experiment 2: ET Patients 1. Currently taking any psychotropic medication 2. Implanted with a non-MRI compatible medical device 3. History of thalamotomy 4. Skin lesions at stimulation site 5. Peripheral neuropathy 6. neurologic exam not consistent with ET 7. Any head trauma resulting in loss of consciousness 8. Diagnosed with a serious mental illness 9. Alcohol or substance abuse or dependence (other than tobacco) in the past week 10. alcohol or caffeine consumption within 12 hours of study enrollment. 11. Currently in treatment for a psychiatric condition 12. Pregnancy (scheduled test) 13. Personal or family history of seizures or epilepsy 14. Claustrophobia or inability to stay still in the MR scanner environment 15. Any metal in the body that is not MRI-compatible 16. Serious history of migraines 17. Hair in dreadlocks, braids, or weave 18. orthopedic forearm or hand problems 19. Inability to adhere to the experimental schedule.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Essential tremor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • BrainsHub

    Leuven, Vlaams-Brabant, 3000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.